Beam Global's estimated fair value is US$3.67 based on 2 Stage Free Cash Flow to Equity Current share price of US$1.89 suggests Beam Global is potentially 49% undervalued Our fair value estimate is 6.

Project Blue Beam is a controversial conspiracy theory claiming that powerful global forces plan to stage a fake alien invasion using advanced holograms and mind control to usher in a New World Order.

Joint effort to explore innovative cancer treatment solutions and broaden options for customers HONG KONG, July 15, 2025 /PRNewswire/ -- AXA China Region ...

Concord Healthcare Group Co., Ltd. ("Concord Healthcare"), a subsidiary of Concord Medical Services Holdings Limited (the "Company") (NYSE: CCM), which subsidiary is listed on the Main Board of The ...

Marking a milestone in precision oncology, Concord treats a rare choroidal melanoma case with cutting-edge proton therapy.